Literature DB >> 33927891

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

S Durnford1, L Boss2, J Bell1.   

Abstract

Entities:  

Keywords:  anaesthesia; cytoreduction surgical procedures; perioperative medicine

Year:  2021        PMID： 33927891      PMCID： PMC8071713          DOI： 10.1016/j.bjae.2020.12.005

Source DB:  PubMed          Journal:  BJA Educ        ISSN： 2058-5349


× No keyword cloud information.
  20 in total

1.  Platinum agents and mitomycin C-specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Grace Hwei Ching Tan; Nicholas Brian Shannon; Claramae Shulyn Chia; Khee Chee Soo; Melissa Ching Ching Teo
Journal:  Int J Hyperthermia       Date:  2017-07-26       Impact factor: 3.914

Review 2.  A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.

Authors:  Tristan D Yan; Deborah Black; Renaldo Savady; Paul H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2006-10-12       Impact factor: 5.344

3.  Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  C Schmidt; M Creutzenberg; P Piso; J Hobbhahn; M Bucher
Journal:  Anaesthesia       Date:  2008-04       Impact factor: 6.955

4.  Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management.

Authors:  Martin Hübner; Shigeki Kusamura; Laurent Villeneuve; Ahmed Al-Niaimi; Mohammad Alyami; Konstantin Balonov; John Bell; Robert Bristow; Delia Cortés Guiral; Anna Fagotti; Luiz Fernando R Falcão; Olivier Glehen; Laura Lambert; Lloyd Mack; Tino Muenster; Pompiliu Piso; Marc Pocard; Beate Rau; Olivia Sgarbura; S P Somashekhar; Anupama Wadhwa; Alon Altman; William Fawcett; Jula Veerapong; Gregg Nelson
Journal:  Eur J Surg Oncol       Date:  2020-08-25       Impact factor: 4.424

5.  Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.

Authors:  Irene Thomassen; Yvette R van Gestel; Bert van Ramshorst; Misha D Luyer; Koop Bosscha; Simon W Nienhuijs; Valery E Lemmens; Ignace H de Hingh
Journal:  Int J Cancer       Date:  2013-08-05       Impact factor: 7.396

6.  Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.

Authors:  P Quere; O Facy; S Manfredi; V Jooste; J Faivre; C Lepage; A-M Bouvier
Journal:  Dis Colon Rectum       Date:  2015-08       Impact factor: 4.585

7.  Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei.

Authors:  Umar S Shariff; Kandiah Chandrakumaran; Sanjeev Dayal; Faheez Mohamed; Tom D Cecil; Brendan J Moran
Journal:  Dis Colon Rectum       Date:  2020-09       Impact factor: 4.585

8.  Peritonectomy procedures.

Authors:  P H Sugarbaker
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

9.  Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.

Authors:  Geert A Simkens; Thijs R van Oudheusden; Misha D Luyer; Simon W Nienhuijs; Grard A Nieuwenhuijzen; Harm J Rutten; Ignace H de Hingh
Journal:  Ann Surg Oncol       Date:  2015-10-06       Impact factor: 5.344

10.  A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Joel M Baumgartner; Thomas G Kwong; Grace L Ma; Karen Messer; Kaitlyn J Kelly; Andrew M Lowy
Journal:  Ann Surg Oncol       Date:  2015-12-17       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.